|
|
|
|
LEADER |
01928nam a22003375i 4500 |
001 |
000278530 |
005 |
20210617155300.0 |
007 |
cr nn 008mamaa |
008 |
160930s2016 ii | s |||| 0|eng d |
020 |
|
|
|a 9788132228370
|
024 |
7 |
|
|a 10.1007/978-81-322-2837-0
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Biomarker Discovery in the Developing World: Dissecting the Pipeline for Meeting the Challenges /
|c edited by Sanjeeva Srivastava.
|
250 |
|
|
|a 1st ed. 2016.
|
260 |
# |
# |
|a New Delhi :
|b Springer India :
|b Imprint: Springer,
|c 2016.
|
300 |
|
|
|a XI, 118 p. 28 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a Chapter 1: Exigencies of biomarker research in developing world: A focus on the dearth of biobanking resources -- Chapter 2: Geographic pervasiveness of cancer: Prospects of novel biomarker and therapeutic research in developing countries using OMICs approaches -- Chapter 3: Omics data processing and analysis -- Chapter 4: Basics of mass spectrometry and its applications in biomarker discovery -- Chapter 5: Angel Philanthropy and Crowdfunding to Accelerate Cancer Research in Developing World -- Chapter 6: Delivering on the Promise of Bioeconomy in Developing World: Link it with Social Innovation and Education -- Chapter 7: Role of proteomics in characterization of biosimilar products -- Chapter 8: Regulatory norms and intellectual property rights for biomarker research.
|
650 |
|
0 |
|a Cancer research.
|
650 |
|
0 |
|a Proteomics.
|
650 |
|
0 |
|a Infectious diseases.
|
650 |
|
0 |
|a Drug resistance.
|
650 |
1 |
4 |
|a Cancer Research.
|
650 |
2 |
4 |
|a Proteomics.
|
650 |
2 |
4 |
|a Infectious Diseases.
|
650 |
2 |
4 |
|a Drug Resistance.
|
700 |
1 |
|
|a Srivastava, Sanjeeva.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|